𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The clinical application of 18F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer

✍ Scribed by Hiroyuki Kato; Masanobu Nakajima; Makoto Sohda; Naritaka Tanaka; Takanori Inose; Tatsuya Miyazaki; Minoru Fukuchi; Noboru Oriuchi; Keigo Endo; Hiroyuki Kuwano

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
151 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of chemotherapy response in p
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography
✍ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m

Positron emission tomography with 18F-fl
Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer
✍ A. David McCollum; Steven C. Burrell; Robert I. Haddad; Charles M. Norris; Roy B 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract ## Background. Conventional imaging is limited in identifying persistent disease after organ‐preserving therapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). We studied the accuracy of positron emission tomography (PET) with ^18^F‐fluoro‐2‐deoxy‐D‐glu

18F-fluorodeoxyglucose–positron emission
18F-fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease
✍ Laurent Arnaud; Zoulikha Malek; Frédérique Archambaud; Aurélie Kas; Dan Toledano 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 2 views

## Abstract ## Objective Erdheim‐Chester disease (ECD) is a rare form of non–Langerhans' cell histiocytosis. The aim of this study was to assess the value of whole‐body scanning with ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) in a large cohort of ECD patients from a single cen

Monitoring of early response to neoadjuv
Monitoring of early response to neoadjuvant chemotherapy in breast cancer with 1H MR spectroscopy: Comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography
✍ Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Toshihiro O'uchi; Naoko Kawano; Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract ## Purpose To assess the efficacy of ^1^H MR spectroscopy (MRS) to evaluate early responses to neoadjuvant chemotherapy in breast cancer patients, as compared to that of the standardized uptake value (SUV) in ^18^F‐fluorodeoxyglucose (FDG) positron emission tomography (PET). ## Materi